Active — Not RecruitingPhase 2

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

United States70 participantsStarted 2023-05-22

Plain-language summary

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (age \>18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment. * Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly * Ability read and respond in English * Ability to provide informed consent to participate in the study Exclusion Criteria: * Patients who are bed bound at baseline (ECOG 4) * Patients who rely on a wheelchair for ambulation

What they're measuring

Number of triage visits

Timeframe: 13 weeks

Trial details

NCT IDNCT05318027

SponsorAbramson Cancer Center at Penn Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Lung Cancer trials